Therapeutic effect of intravenous infusion of perfluorocarbon emulsion on LPS-induced acute lung injury in rats

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Hou, Shike ^a   Ding, Hui ^a   Lv, Qi ^a   Yin, Xiaofeng ^a   Song, Jianqi ^a   Landén, Ning Xu ^b   Fan, Haojun ^a  

^a Chinese Peoples Armed Police Forces   (China)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; FLUOROCARBON; INTERCELLULAR ADHESION MOLECULE 1; MYELOPEROXIDASE; SODIUM CHLORIDE;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD OXYGEN TENSION; CONTROLLED STUDY; EMULSION; ENDOTHELIUM CELL; FEMORAL VEIN; IN VIVO STUDY; LUNG WEIGHT; MALE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; RAT;

ACUTE LUNG INJURY; ANIMALS; EMULSIONS; FLUOROCARBONS; INFUSIONS, INTRAVENOUS; LIPOPOLYSACCHARIDES; MALE; RATS; RATS, WISTAR;

EID: 84899939214     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087826     Document Type: Article

References (47)

1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE (1967) Acute respiratory distress in adults. Lancet 2: 319-323.
2. Zhou X, Dai Q, Huang X (2012) Neutrophils in acute lung injury. Front Biosci 17: 2278-2283.
3. Tsushima K, King LS, Aggarwal NR, Gorordo AD, D'Alessio FR, et al. (2009) Acute Lung Injury Review. Intern Med 48: 621-630.
4. Lu Y, Song Z, Zhou X, Huang S, Zhu D, et al. (2004) A 12-month clinical survey of incidence and outcome of acute respiratory distress syndrome in Shanghai intensive care units. Intensive Care Med 30: 2197-2203. (Pubitemid 40174255)
5. Garber BG, H'ebert PC, Yelle JD, Hodder RV, McGowan J (1996) Adult respiratory distress syndrome: a systematic overview of incidence and risk factors. Crit Care Med 24: 687-695.
6. Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, et al. (2004) Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 351: 327-336.
7. Bollen CW, van Well GT, Sherry T, Beale RJ, Shah S, et al. (2005) High frequency oscillatory ventilation compared with conventional mechanical ventilation in adult respiratory distress syndrome: a randomized controlled trial. Crit Care 9: R430-439.
8. Young D, Lamb SE, Shah S, MacKenzie I, Tunnicliffe W, et al. (2013) High-frequency oscillation for acute respiratory distress syndrome. N Engl J Med 368: 806-813.
9. Hale DF, Cannon JW, Batchinsky AI, Cancio LC, Aden JK, et al. (2012) Prone positioning improves oxygenation in adult burn patients with severe acute respiratory distress syndrome. J Trauma Acute Care Surg 72: 1634-1639.
10. Dickinson S, Park PK, Napolitano LM (2011) Prone-positioning therapy in ARDS. Crit Care Clin 27: 511-523.
11. Taylor RW, Zimmerman JL, Dellinger RP, Straube RC, Criner GJ, et al. (2004) Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA 291: 1603-1609. (Pubitemid 38552433)
12. Angus DC, Clermont G, Linde-Zwirble WT, Musthafa AA, Dremsizov TT, et al. (2006) Healthcare costs and long-term outcomes after acute respiratory distress syndrome: A phase III trial of inhaled nitric oxide. Crit Care Med 34: 2883-2890. (Pubitemid 44808728)
13. Thompson BT (2003) Glucocorticoids and acute lung injury. Crit Care Med 31: S253-257.
14. Perkins GD, McAuley DF, Thickett DR, Gao F (2006) The beta agonist lung injury trial (BALTI): a randomised placebo-controlled clinical trial. Am J Respir Crit Care Med 173: 281-287. (Pubitemid 43209082)
15. Gao Smith F, Perkins GD, Gates S, Young D, McAuley DF, et al. (2012) BALTI-2 study investigators: Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet 379: 229-235.
16. Taut FJ, Rippin G, Schenk P, Findlay G, Wurst W, et al. (2008) A Search for subgroups of patients with ARDS who may benefit from surfactant replacement therapy: a pooled analysis of five studies with recombinant surfactant protein-C surfactant (Venticute). Chest 134: 724-732.
17. Bernard G, Wheeler A, Naum C, Morris P, Nelson L, et al. (1999) A placebo controlled, randomised trail of IL-10 in acute lung injury (ALI). Chest 116 (Suppl): 260S.
18. Faithfull NS, Weers JG (1998) Perfluorocarbon compounds. Vox Sang 74 Suppl 2: 243-248. (Pubitemid 28379789)
19. Castro CI, Briceno JC (2010) Perfluorocarbon-based oxygen carriers: review of products and trials. Artif Organs 34: 622-634.
20. Greenspan JS, Wolfson MR, Shaffer TH (2000) Liquid ventilation. Semin Perinatol 24: 396-405. (Pubitemid 32039053)
21. Riess JG (2006) Perfluorocarbon-based oxygen delivery. Artif Cells Blood Substit Immobil Biotechnol 34: 567-580.
22. Greenspan JS, Wolfson MR, Rubenstein SD, Shaffer TH (1990) Liquid ventilation of human preterm neonates. J Pediatr 117: 106-111. (Pubitemid 20217507)
23. Hadjiliadis D (2000) Partial liquid ventilation. Semin Respir Crit Care Med 21: 175-181.
24. Yoxall CW, Subhedar NV, Shaw NJ (1997) Liquid ventilation in the preterm neonate. Thorax 52 Suppl 3: S3-8. (Pubitemid 27404964)
25. Wang X, Zhang J, Li X, Liu Y, Yang H, et al. (2013) Sustained Improvement of Gas Exchange and Lung Mechanics by Vaporized Perfluorocarbon Inhalation in Piglet Acute Lung Injury Model. Clin Respir J. 2013 Sep 13. doi: 10.1111/crj.12053. [Epub ahead of print]
26. Spahn DR (1999) Blood substitutes. Artificial oxygen carriers: perfluorocarbon emulsions. Crit Care 3:R93-97.
27. Kerins DM (1994) Role of perfluorocarbon Fluosol-DA in coronary angioplasty. Am J Med Sci 307: 218-221.
28. Spiess BD. (2009) Perfluorocarbon emulsions as a promising technology: a review of tissue and vascular gas dynamics. J Appl Physiol 106:1444-52.
29. Keipert PE. (2001) Perflubron emulsion (Oxygent(tm)): a temporary intravenous oxygen carrier. Anasthesiol Intensivmed Notfallmed Schmerzther 36 Suppl 2:S104-106.
30. Sharma J, Rastogi P, Creer MH, McHowat J (2009) Polymorphonuclear leukocytes isolated from umbilical cord blood as a useful research tool to study adherence to cell monolayers. J Immunol Methods 351: 30-35.
31. Butcher EC (1991) Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67: 1033-1036.
32. Solovjov DA, Pluskota E, Plow EF (2005) Distinct roles for the alpha and beta subunits in the functions of integrin alphaMbeta2. J Biol Chem 280: 1336-45.
33. Shen Y, Wang D, Wang X (2011) Role of CCR2 and IL-8 in acute lung injury: a new mechanism and therapeutic target. Expert Rev Respir Med 5: 107-114.
34. Wolfson MR, Shaffer TH (2004) Liquid ventilation: an adjunct for respiratory management. Paediatr Anaesth 14: 15-23. (Pubitemid 38177983)
35. Albaghdadi AS, Brooks LA, Pretorius AM, Kerber RE (2010) Perfluorocarbon induced intra-arrest hypothermia does not improve survival in a swine model of asphyxial cardiac arrest. Resuscitation 81: 353-358.
36. Shashikant BN, Miller TL, Jeng MJ, Davis J, Shaffer TH, et al. (2005) Differential impact of perfluorochemical physical properties on the physiologic, histologic, and inflammatory profile in acute lung injury. Crit Care Med 33: 1096-1103. (Pubitemid 40638185)
37. Everhart MB, Han W, Sherrill TP, Arutiunov M, Polosukhin VV, et al. (2006) Duration and intensity of NF-kappaB activity determine the severity of endotoxin-induced acute lung injury. J Immunol 176: 4995-5005.
38. Chopra M, Reuben JS, Sharma AC (2009) Acute lung injury:apoptosis and signaling mechanisms. Exp Biol Med 234: 361-371.
39. Gale SC, Gorman GD, Copeland JG, McDonagh PF (2007) Perflubron emulsion prevents PMN activation and improves myocardial functional recovery after cold ischemia and reperfusion. J Surg Res 138: 135-140. (Pubitemid 46227461)
40. Chang H, Kuo FC, Lai YS, Chou TC (2005) Inhibition of inflammatory responses by FC-77, a perfluorochemical, in lipopolysaccharide-treated RAW 264.7 macrophages. Intensive Care Med 31: 977-984. (Pubitemid 40941732)
41. Baba A, Kim YK, Zhang H, Liu M, Slutsky AS (2000) Perfluorocarbon blocks tumor necrosis factor-alpha-induced interleukin-8 release from alveolar epithelial cells in vitro. Crit Care Med 28: 1113-1118. (Pubitemid 30262088)
42. Michetti C, Coimbra R, Hoyt DB, Loomis W, Junger W, et al. (2003) Pentoxifylline reduces acute lung injury in chronic endotoxemia. J Surg Res 115: 92-99. (Pubitemid 37323953)
43. Zhang X, Wu D, Jiang X (2009) Icam-1 and acute pancreatitis complicated by acute lung injury. JOP 10: 8-14.
44. Gardinali M, Borrelli E, Chiara O, Lundberg C, Padalino P, et al. (2000) Inhibition of CD11-CD18 complex prevents acute lung injury and reduces mortality after peritonitis in rabbits. Am J Respir Crit Care Med 161: 1022-1029. (Pubitemid 30171767)
45. Ma XG, Cao XY (2006) Protective effects of colquhounia root tablet against oleic acid induced acute lung injury in rats. Chin J Anesthesiol 26: 363-365.
46. Wyman TH, Bjornsen AJ, Elzi DJ, Smith CW, England KM, et al. (2002) A two-insult in vitro model of PMN-mediated pulmonary endothelial damage: requirements for adherence and chemokine release. Am J Physiol Cell Physiol, 283: C1592-1603. (Pubitemid 35340590)
47. Doerschuk CM, Quinlan WM, Doyle NA, Bullard DC, Vestweber D, et al. (1996) The role of P-selectin and ICAM-1 in acute lung injury as determined using blocking antibodies and mutant mice. J Immunol 157: 4609-4614. (Pubitemid 126449383)